找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adjuvant Therapy of Primary Breast Cancer; Hans-J?rg Senn,Aron Goldhirsch,Bruno Osterwalder Conference proceedings 1989 Springer-Verlag Be

[復制鏈接]
樓主: 你太謙虛
31#
發(fā)表于 2025-3-26 23:32:57 | 只看該作者
Dirichlet and Polya tree process,subsequent course (Kurtz et al. 1988 a). The purpose of this paper is to analyze the development of breast recurrence as a function of time, as well as to study the prognosis following treatment of local failure.
32#
發(fā)表于 2025-3-27 04:28:44 | 只看該作者
Inference for Location Parameter,n of patients whose tumors are more responsive to a given treatment (e.g. patients with estrogen-receptor(ER)-positive tumors, who are receiving adjuvant endocrine therapy) (Ludwig Breast Cancer Study Group 1984). The use of sequential non-cross-resistant combinations also appears to enhance effectiveness (Perloff et al. 1986).
33#
發(fā)表于 2025-3-27 09:01:44 | 只看該作者
34#
發(fā)表于 2025-3-27 11:09:33 | 只看該作者
35#
發(fā)表于 2025-3-27 17:21:17 | 只看該作者
36#
發(fā)表于 2025-3-27 20:03:46 | 只看該作者
Dirichlet and Polya tree process,reasing doses through a multilog cell kill model. In this regard, the alkylating agents more closely resemble radiotherapy. The lack of cross-resistance among the alkylating agents in both in vitro and in vivo models has important implications for clinical treatment strategies (Frei et al. 1985; Frei et al., in press; Teicher et al. 1986).
37#
發(fā)表于 2025-3-28 00:18:58 | 只看該作者
38#
發(fā)表于 2025-3-28 02:41:26 | 只看該作者
0080-0015 in this disease, the benefits of therapy are relatively mod- est, the availability and interpretation of the data from trials be- comes an issue of primary importance. The effects of present treat- ment are in fact such that more patients relapse despite therapy than are estimated to benefit from i
39#
發(fā)表于 2025-3-28 08:30:31 | 只看該作者
40#
發(fā)表于 2025-3-28 11:14:12 | 只看該作者
Inference for Location Parameter,research. There is no question that such a development, if proven correct, will result in very significant practical alterations of the orthodox management of breast cancer. Therefore, before its full implementation, rigorous testing in clinical trials will be required.
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 16:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
西藏| 杂多县| 红安县| 济源市| 奉贤区| 武隆县| 文水县| 栖霞市| 宁波市| 龙口市| 勃利县| 宁河县| 呼伦贝尔市| 宁河县| 清新县| 逊克县| 崇州市| 西盟| 天峨县| 丹寨县| 周宁县| 桐柏县| 浪卡子县| 湘潭市| 二连浩特市| 湖北省| 寻甸| 湖口县| 太康县| 商水县| 天等县| 湄潭县| 和林格尔县| 逊克县| 明水县| 弋阳县| 图木舒克市| 葵青区| 宁武县| 鲜城| 淄博市|